Connect with us

Politics

Nigeria, 2 others to begin Lassa fever vaccine trials

Published

on

lassa fever
Kindly Share This

The United States said on Monday a new phase of Lassa fever vaccine clinical trials would begin in Nigeria and two other countries in West Africa soon.

In a statement issued by the Public Affairs Unit of the US Diplomatic Mission to Nigeria, said the vaccine trials would also take place in Liberia and Sierra Leone.

The statement added that the International AIDS Vaccine Initiative was awarded €22.8 million by the European and Developing Countries Clinical Trial Partnership and the Coalition for Epidemic Preparedness Innovations to conduct a Phase IIB trial of the IAVI Lassa fever vaccine candidate among adults and children in the three countries.

Read Also MUST READ: More Revelation On The Chidinma/Ataga Tango

The statement read: “This joint award supports an international collaboration across Africa, Europe, and North America, called the ‘Lassa Fever Vaccine Efficacy and Prevention for West Africa’ which will also strengthen the research capacity of investigational sites where Lassa fever outbreaks and disease occur frequently.

“The LEAP4WA consortium consists of the following members: IAVI Inc., U.S.; IAVI Sichting, Netherlands; Tulane University School of Public Health and Tropical Medicine, U.S.; Ministry of Health and Sanitation/Kenema Government Hospital in Sierra Leone; Imperial College of Science Technology and Medicine, U.K.; University of Liberia, Liberia; Epicentre, France; and Henry M. Jackson Foundation Medical Research International Ltd/Gte(HJFMRI), Nigeria.

“In Nigeria, HJFMRI will conduct the study at its Clinical Research Centre (CRC) supported by the Walter Reed Army Institute of Research.

“Other supported WRAIR Lassa projects being implemented at the CRC and other sites across Nigeria include a Lassa incidence study in collaboration with the African Centre of Excellence for Genomics of Infectious Diseases, a Lassa seroprevalence study, and a potential opportunity for a CEPI-funded Phase IIa Lassa vaccine study through a WRAIR/IAVI collaboration.”

Read Also Chidinma Again: See The Fake Items Police Recovered From Killer Of Usifo Ataga [FULL LIST]

Kindly Share This
Dear Reader, Fetching good and credible news information is tedious and requires huge finance. We are soliciting support from our readers and fans. For as low as N1,000  you can be a part of our golden membership. Your support would go a long way in assisting us to continue guaranteeing quality news to our readers across the globe. Bank transfers can be made to: Zenith Bank 1014932118 Ireporteronline communications Inquiries: Email: [email protected] Whatsapp: +234 7032341798 FOR BUSSINESS ADVERT CLICK THE WHATSAPP IMAGE BELOW
Advertisement
Click to comment

Leave a Reply

Your email address will not be published.

Advertisement

Trending